178 related articles for article (PubMed ID: 36599394)
21. Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses.
Lin YW; Wang LC; Lee CK; Chen SH
Sci Rep; 2018 Aug; 8(1):12184. PubMed ID: 30111869
[TBL] [Abstract][Full Text] [Related]
22. A monoclonal antibody to ameliorate central nervous system infection and improve survival in a murine model of human Enterovirus-A71 encephalomyelitis.
Tan SH; Ong KC; Perera D; Wong KT
Antiviral Res; 2016 Aug; 132():196-203. PubMed ID: 27340013
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
[TBL] [Abstract][Full Text] [Related]
24. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
25. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
26. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
27. Exosomes Facilitate Transmission of Enterovirus A71 From Human Intestinal Epithelial Cells.
Huang HI; Lin JY; Chiang HC; Huang PN; Lin QD; Shih SR
J Infect Dis; 2020 Jul; 222(3):456-469. PubMed ID: 32271384
[TBL] [Abstract][Full Text] [Related]
28. Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication.
Helgers LC; Bhoekhan MS; Pajkrt D; Wolthers KC; Geijtenbeek TBH; Sridhar A
Microbiol Spectr; 2022 Dec; 10(6):e0282222. PubMed ID: 36222686
[TBL] [Abstract][Full Text] [Related]
29. A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.
Sun S; Bian L; Gao F; Du R; Hu Y; Fu Y; Su Y; Wu X; Mao Q; Liang Z
Antiviral Res; 2019 Jan; 161():108-115. PubMed ID: 30503887
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.
Xing J; Wang K; Wang G; Li N; Zhang Y
Arch Virol; 2022 Dec; 167(12):2483-2501. PubMed ID: 36171507
[TBL] [Abstract][Full Text] [Related]
31. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
32. Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 mice.
Peterson CJ; Hurst BL; Evans WJ; Van Wettere AJ; Gibson SA; Smee DF; Tarbet EB
Virology; 2023 Mar; 580():62-72. PubMed ID: 36780728
[TBL] [Abstract][Full Text] [Related]
33. Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus.
Yeung ML; Jia L; Yip CCY; Chan JFW; Teng JLL; Chan KH; Cai JP; Zhang C; Zhang AJ; Wong WM; Kok KH; Lau SKP; Woo PCY; Lo JYC; Jin DY; Shih SR; Yuen KY
J Clin Invest; 2018 Nov; 128(11):5163-5177. PubMed ID: 30153112
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model.
Liou AT; Liao CC; Chou SF; Chang YS; Chang CS; Shih C
J Biomed Sci; 2019 Nov; 26(1):93. PubMed ID: 31711481
[TBL] [Abstract][Full Text] [Related]
35. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 May; 91(9):. PubMed ID: 28250116
[TBL] [Abstract][Full Text] [Related]
36. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
37. An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection.
Cheng YW; Chuang YC; Huang SW; Liu CC; Wang JR
J Biomed Sci; 2022 Feb; 29(1):10. PubMed ID: 35130884
[TBL] [Abstract][Full Text] [Related]
38. Enterovirus A71 crosses a human blood-brain barrier model through infected immune cells.
Gaume L; Chabrolles H; Bisseux M; Lopez-Coqueiro I; Dehouck L; Mirand A; Henquell C; Gosselet F; Archimbaud C; Bailly J-L
Microbiol Spectr; 2024 Jun; 12(6):e0069024. PubMed ID: 38752731
[TBL] [Abstract][Full Text] [Related]
39. Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.
Kobayashi K; Nishimura H; Mizuta K; Nishizawa T; Chu ST; Ichimura H; Koike S
J Virol; 2021 Nov; 95(23):e0151521. PubMed ID: 34523967
[TBL] [Abstract][Full Text] [Related]
40. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
